Life Sciences and Healthcare to the USA

The Bio International Convention is one of the world’s largest life sciences conferences, bringing together global health companies and senior decision-makers for a week of high-value engagement in San Diego.

The USA is the powerhouse in life sciences innovation. Alone, it accounts for 36% of global biotechnology market revenue, which is slated to reach USD $5.7 trillion by 2034. The USA produces about 20% of the world’s pharmaceuticals.

Consumer demand for advanced health solutions is strong in the USA, with per capita health spending double that of other OECD countries. There continues to be strong growth, driven by high consumer awareness, demand for self-medication, and advanced infrastructure.

An ageing population, widespread chronic disease, and high medical costs will also continue to drive demand for health innovation in the market. The number of Americans aged 65+ is projected to increase from 58 million to 82 million by 2050, demonstrating a massive demographic shift that drives up the need for long-term care and medical spending. 

Bio International Convention, 22-25 June 2026, San Diego.  

In-person attendance by a company representatives is compulsory. 

• Build partnerships and connections directly with potential customers, business partners, investors and key decision makers at the Bio International Convention, 22-25 June 2026.
• Gain in-depth insights from industry experts, explore market trends amid policy changes, increase awareness of emerging appetite on new market entry strategy model, understand regulatory pathway and forge collaborations in a global marketplace of the entire biotechnology ecosystem.
• Showcase and build credibility, visibility and market presence for your business to a global audience. There will be a Team Australia activation at BIO 2026.
• Engage with diverse and global potential business partners and stakeholders from over 55 countries and discover emerging opportunities.
• Receive tailored support from NSW government onshore and offshore representatives to strengthen your market entry strategy into the USA.

Applicant businesses should be able to demonstrate:

• Funding or revenue to support USA market expansion and commitment to establish business partnerships in the USA in the next ~12 months.
• A clear pathway to profitability or already a profitable business with a clearly articulated regulatory pathway and reimbursement plan.
• Identified potential customers and partners in the USA and/or already have some market traction
• Clinically validated (if product is subject to trial) or will be in the next 12-18 months.
• Be up to date with reporting of outcomes derived from previous Investment NSW support (please contact hanh.hoang@investment.nsw.gov.au if you need to update your reporting).

Applicants who have not previously participated in a Going Global Program to the United States will be given priority to participate in this program.

Note: Local Health Districts are also invited to attend BIO as a NSW in-person delegate and be showcased in NSW's conference promotional material. If you want to attend BIO International Convention as one of these delegates, please contact hanh.hoang@investment.nsw.gov.au. You will be responsible for your own BIO partnering registration.

Investment NSW will support businesses to be part of the NSW delegates at Bio International Convention, which includes:

• Pre-event briefing and preparations, and networking with market experts.
• Representation and participation at Investment NSW event(s) and priority access to Investment NSW-supported events (TBC), fostering high-value connections with potential investors, customers and partners.
• In-person business partnering at Bio International Convention and Networking events.
• Promotion in Investment NSW’s Export Digital Promotion platform.
• In-market support from Investment NSW’s Trade and Investment Director Americas (USA based).
• Ongoing one-to-one support with a dedicated Investment NSW Export Adviser following the conclusion of the program.

Please note: The above does not include airfares, accommodation, travel insurance, visas, meals, ground transport, any cost associated with freight for product samples and any additional cost that are considered out of scope of the core offer.

Applications open on 10 November 2025 and close on 11 January 2026. 

Applications will be notified of the outcome around the end of February 2026. 

Contact